CXCL10 and systemic lupus erythematosus: 0001, S2 Table), neither the presence nor absence of these medications altered the pattern of IL-6 and IP-10 levels in FDRs, SLE patients, and controls, such that FDRs continued to have the highest levels of IL-6 and IP-10, followed by cases and controls (S1 Fig).